Steven D. Ness, MD

Assistant Professor, Ophthalmology

(617) 414-2020
85 E. Concord St

Biography

Expertise includes: Retinal disease including diabetic retinopathy; Macular degeneration; Retinal vein occlusions; Retinal detachment.

Education

  • University of Maryland School of Medicine, MD
  • Yale University, BA

Publications

  • Published on 8/7/2017

    Song W, Zhang L, Ness S, Yi J. Wavelength-dependent optical properties of melanosomes in retinal pigmented epithelium and their changes with melanin bleaching: a numerical study. Biomed Opt Express. 2017 Sep 01; 8(9):3966-3980. PMID: 29026682.

    Read at: PubMed
  • Published on 1/1/2011

    Abedi G, Subramanian ML, Feinberg E, Ness SD. The role of intravenous immunoglobulin in treatment of acute retinal necrosis. Retin Cases Brief Rep. 2011; 5(4):363-5. PMID: 25390437.

    Read at: PubMed
  • Published on 10/1/2010

    Subramanian ML, Abedi G, Ness S, Ahmed E, Fenberg M, Daly MK, Houranieh A, Feinberg EB. Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial. Eye (Lond). 2010 Nov; 24(11):1708-15. PMID: 20885427.

    Read at: PubMed
  • Published on 10/2/2009

    Subramanian ML, Ness S, Abedi G, Ahmed E, Daly M, Feinberg E, Bhatia S, Patel P, Nguyen M, Houranieh A. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol. 2009 Dec; 148(6):875-82.e1. PMID: 19800611.

    Read at: PubMed
  • Published on 6/1/2005

    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Arch Ophthalmol. 2005 Jun; 123(6):765-73. PMID: 15955977.

    Read at: PubMed

View all profiles